Zai Lab (ZLAB) Stock Forecast, Price Target & Predictions
ZLAB Stock Forecast
Zai Lab stock forecast is as follows: an average price target of $50.00 (represents a 87.13% upside from ZLAB’s last price of $26.72) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
ZLAB Price Target
The average price target for Zai Lab (ZLAB) is $50.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $50.00 to $50.00. This represents a potential 87.13% upside from ZLAB's last price of $26.72.
ZLAB Analyst Ratings
According to 3 Wall Street analysts, Zai Lab's rating consensus is 'Buy'. The analyst rating breakdown for ZLAB stock is 0 'Strong Buy' (0.00%), 3 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Zai Lab Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 27, 2024 | Jack Lin | Morgan Stanley | $50.00 | $23.63 | 111.60% | 87.13% |
| Apr 21, 2022 | Leerink Partners | $101.00 | $42.88 | 135.54% | 277.99% |
The latest Zai Lab stock forecast, released on Sep 27, 2024 by Jack Lin from Morgan Stanley, set a price target of $50.00, which represents a 111.60% increase from the stock price at the time of the forecast ($23.63), and a 87.13% increase from ZLAB last price ($26.72).
Zai Lab Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 1 |
| Avg Price Target | - | $50.00 | $50.00 |
| Last Closing Price | $26.72 | $26.72 | $26.72 |
| Upside/Downside | -100.00% | 87.13% | 87.13% |
In the current month, the average price target of Zai Lab stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Zai Lab's last price of $26.72. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 27, 2024 | Morgan Stanley | Overweight | Overweight | Hold |
| Apr 09, 2024 | Bank of America Securities | Buy | Buy | Hold |
| Oct 26, 2023 | Goldman Sachs | Buy | Buy | Hold |
Zai Lab's last stock rating was published by Morgan Stanley on Sep 27, 2024. The company gave ZLAB a "Overweight" rating, the same as its previous rate.
Zai Lab Financial Forecast
Zai Lab Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | $69.23M | $68.86M | $62.80M | $62.60M | $57.54M | $48.18M | $46.72M | $44.17M | $43.10M | $36.94M | $20.10M | $15.09M | $14.65M | $10.99M | $8.22M | $4.65M |
| Avg Forecast | $128.50M | $122.30M | $117.00M | $112.30M | $108.88M | $102.24M | $93.16M | $75.24M | $72.14M | $66.41M | $70.48M | $65.12M | $62.79M | $53.75M | $47.13M | $44.58M | $47.89M | $43.77M | $27.41M | $17.66M | $25.45M | $15.83M | $-1.64M | $36.00K | $10.00M |
| High Forecast | $134.45M | $127.96M | $122.42M | $121.84M | $112.17M | $103.09M | $93.16M | $75.24M | $76.07M | $69.27M | $73.74M | $68.14M | $65.70M | $53.75M | $47.13M | $44.58M | $47.89M | $43.77M | $27.41M | $17.66M | $25.45M | $15.83M | $-1.64M | $36.00K | $10.00M |
| Low Forecast | $124.07M | $118.09M | $112.97M | $105.37M | $106.14M | $101.39M | $93.16M | $75.24M | $67.70M | $63.55M | $68.05M | $62.88M | $60.63M | $53.75M | $47.13M | $44.58M | $47.89M | $43.77M | $27.41M | $17.66M | $25.45M | $15.83M | $-1.64M | $36.00K | $10.00M |
| # Analysts | 1 | 1 | 1 | 2 | 5 | 2 | 2 | 2 | 5 | 2 | 2 | 2 | 1 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 |
| Surprise % | - | - | - | - | - | - | - | - | - | 1.04% | 0.98% | 0.96% | 1.00% | 1.07% | 1.02% | 1.05% | 0.92% | 0.98% | 1.35% | 1.14% | 0.59% | 0.93% | -6.71% | 228.28% | 0.46% |
Zai Lab's average Quarter revenue forecast for Dec 23 based on 5 analysts is $72.14M, with a low forecast of $67.70M, and a high forecast of $76.07M. ZLAB's average Quarter revenue forecast represents a 4.21% increase compared to the company's last Quarter revenue of $69.23M (Sep 23).
Zai Lab EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 2 | 5 | 2 | 2 | 2 | 5 | 2 | 2 | 2 | 1 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 |
| EBITDA | - | - | - | - | - | - | - | - | - | $-83.57M | $-89.50M | $-78.43M | $-136.00M | $-126.36M | $-96.86M | $-77.75M | $-209.95M | $-94.78M | $-161.80M | $-231.46M | $-75.14M | $-62.55M | $-79.54M | $-46.86M | $-45.14M |
| Avg Forecast | $-128.50M | $-122.30M | $-117.00M | $-112.30M | $-108.88M | $-102.24M | $-93.16M | $-75.24M | $-72.14M | $-66.41M | $-70.48M | $-65.12M | $-16.95M | $-53.75M | $-47.13M | $-44.58M | $-47.89M | $-43.77M | $-27.41M | $-178.77M | $-25.45M | $-15.83M | $1.64M | $-36.00K | $-18.13M |
| High Forecast | $-124.07M | $-118.09M | $-112.97M | $-105.37M | $-106.14M | $-101.39M | $-93.16M | $-75.24M | $-67.70M | $-63.55M | $-68.05M | $-62.88M | $-13.56M | $-53.75M | $-47.13M | $-44.58M | $-47.89M | $-43.77M | $-27.41M | $-143.01M | $-25.45M | $-15.83M | $1.64M | $-36.00K | $-14.50M |
| Low Forecast | $-134.45M | $-127.96M | $-122.42M | $-121.84M | $-112.17M | $-103.09M | $-93.16M | $-75.24M | $-76.07M | $-69.27M | $-73.74M | $-68.14M | $-20.34M | $-53.75M | $-47.13M | $-44.58M | $-47.89M | $-43.77M | $-27.41M | $-214.52M | $-25.45M | $-15.83M | $1.64M | $-36.00K | $-21.75M |
| Surprise % | - | - | - | - | - | - | - | - | - | 1.26% | 1.27% | 1.20% | 8.02% | 2.35% | 2.06% | 1.74% | 4.38% | 2.17% | 5.90% | 1.29% | 2.95% | 3.95% | -48.56% | 1301.64% | 2.49% |
undefined analysts predict ZLAB's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Zai Lab's previous annual EBITDA (undefined) of $NaN.
Zai Lab Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 2 | 5 | 2 | 2 | 2 | 5 | 2 | 2 | 2 | 1 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 |
| Net Income | - | - | - | - | - | - | - | - | - | $-69.15M | $-120.89M | $-28.77M | $-26.25M | $-158.96M | $-136.07M | $-84.80M | $-203.94M | $-109.28M | $-155.67M | $-238.92M | $-57.39M | $-50.96M | $-77.02M | $-49.52M | $-40.56M |
| Avg Forecast | $-31.41M | $-53.50M | $-56.94M | $-58.90M | $-68.33M | $-76.85M | $-69.54M | $-90.80M | $-84.01M | $-102.50M | $-77.59M | $-93.08M | $-17.43M | $-121.87M | $-104.98M | $-122.99M | $-130.17M | $-114.98M | $-103.61M | $-179.89M | $-165.42M | $-165.42M | $-58.10M | $-61.42M | $-18.65M |
| High Forecast | $-30.01M | $-51.10M | $-54.39M | $-48.51M | $-48.95M | $-73.41M | $-66.42M | $-86.73M | $-75.32M | $-97.90M | $-74.12M | $-88.91M | $-13.95M | $-121.87M | $-104.98M | $-122.99M | $-130.17M | $-114.98M | $-103.61M | $-143.91M | $-165.42M | $-165.42M | $-58.10M | $-61.42M | $-14.92M |
| Low Forecast | $-33.30M | $-56.72M | $-60.36M | $-69.30M | $-79.55M | $-81.48M | $-73.72M | $-96.26M | $-93.66M | $-108.67M | $-82.26M | $-98.68M | $-20.92M | $-121.87M | $-104.98M | $-122.99M | $-130.17M | $-114.98M | $-103.61M | $-215.86M | $-165.42M | $-165.42M | $-58.10M | $-61.42M | $-22.37M |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.67% | 1.56% | 0.31% | 1.51% | 1.30% | 1.30% | 0.69% | 1.57% | 0.95% | 1.50% | 1.33% | 0.35% | 0.31% | 1.33% | 0.81% | 2.18% |
Zai Lab's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. ZLAB's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Zai Lab SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 2 | 5 | 2 | 2 | 2 | 5 | 2 | 2 | 2 | 1 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 |
| SG&A | - | - | - | - | - | - | - | - | - | $68.55M | $67.92M | $62.51M | $72.02M | $66.56M | $63.40M | $56.99M | $69.58M | $59.00M | $54.41M | $35.84M | $40.97M | $27.87M | $23.76M | $18.71M | $23.02M |
| Avg Forecast | $294.45M | $280.25M | $268.10M | $257.33M | $249.48M | $234.28M | $213.48M | $8.42M | $165.31M | $152.17M | $161.50M | $9.00M | $8.65M | $123.16M | $107.98M | $9.63M | $109.75M | $100.31M | $62.80M | $40.46M | $58.32M | $36.28M | $-3.75M | $82.49K | $9.25M |
| High Forecast | $308.09M | $293.22M | $280.51M | $279.20M | $257.02M | $236.23M | $213.48M | $10.10M | $174.32M | $158.73M | $168.98M | $10.80M | $10.37M | $123.16M | $107.98M | $11.55M | $109.75M | $100.31M | $62.80M | $40.46M | $58.32M | $36.28M | $-3.75M | $82.49K | $11.10M |
| Low Forecast | $284.30M | $270.59M | $258.86M | $241.44M | $243.21M | $232.34M | $213.48M | $6.73M | $155.14M | $145.62M | $155.94M | $7.20M | $6.92M | $123.16M | $107.98M | $7.70M | $109.75M | $100.31M | $62.80M | $40.46M | $58.32M | $36.28M | $-3.75M | $82.49K | $7.40M |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.45% | 0.42% | 6.95% | 8.33% | 0.54% | 0.59% | 5.92% | 0.63% | 0.59% | 0.87% | 0.89% | 0.70% | 0.77% | -6.33% | 226.86% | 2.49% |
Zai Lab's average Quarter SG&A projection for Dec 23 is $165.31M, based on 5 Wall Street analysts, with a range of $155.14M to $174.32M. The forecast indicates a 141.14% rise compared to ZLAB last annual SG&A of $68.55M (Sep 23).
Zai Lab EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 2 | 5 | 2 | 2 | 2 | 5 | 2 | 2 | 2 | 1 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 |
| EPS | - | - | - | - | - | - | - | - | - | $-0.71 | $-0.00 | $-0.30 | $-0.27 | $-1.66 | $-1.42 | $-0.89 | $-2.15 | $-1.15 | $-1.67 | $-2.70 | $-0.65 | $-0.68 | $-1.03 | $-0.68 | $-0.56 |
| Avg Forecast | $-0.32 | $-0.55 | $-0.58 | $-0.60 | $-0.70 | $-0.78 | $-0.71 | $-0.92 | $-0.86 | $-1.04 | $-0.79 | $-0.95 | $-1.11 | $-1.25 | $-1.08 | $-1.26 | $-1.33 | $-1.18 | $-1.06 | $-1.58 | $-1.70 | $-1.70 | $-0.60 | $-0.63 | $-0.94 |
| High Forecast | $-0.31 | $-0.52 | $-0.55 | $-0.49 | $-0.50 | $-0.75 | $-0.68 | $-0.88 | $-0.77 | $-1.00 | $-0.75 | $-0.91 | $-1.06 | $-1.25 | $-1.08 | $-1.26 | $-1.33 | $-1.18 | $-1.06 | $-1.58 | $-1.70 | $-1.70 | $-0.60 | $-0.63 | $-0.94 |
| Low Forecast | $-0.34 | $-0.58 | $-0.61 | $-0.71 | $-0.81 | $-0.83 | $-0.75 | $-0.98 | $-0.95 | $-1.11 | $-0.84 | $-1.01 | $-1.18 | $-1.25 | $-1.08 | $-1.26 | $-1.33 | $-1.18 | $-1.06 | $-1.58 | $-1.70 | $-1.70 | $-0.60 | $-0.63 | $-0.94 |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.68% | 0.00% | 0.32% | 0.24% | 1.33% | 1.32% | 0.71% | 1.61% | 0.98% | 1.57% | 1.71% | 0.38% | 0.40% | 1.73% | 1.08% | 0.60% |
According to undefined Wall Street analysts, Zai Lab's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to ZLAB previous annual EPS of $NaN (undefined).
Zai Lab Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| CCCC | C4 Therapeutics | $4.05 | $20.00 | 393.83% | Buy |
| CGEM | Cullinan Oncology | $11.49 | $34.00 | 195.91% | Buy |
| LEGN | Legend Biotech | $34.68 | $89.60 | 158.36% | Buy |
| ERAS | Erasca | $2.63 | $6.00 | 128.14% | Buy |
| APLS | Apellis Pharmaceuticals | $34.53 | $70.80 | 105.04% | Buy |
| ZLAB | Zai Lab | $26.97 | $50.00 | 85.39% | Buy |
| AKRO | Akero Therapeutics | $30.61 | $50.00 | 63.35% | Buy |
| ASND | Ascendis Pharma | $140.30 | $211.14 | 50.49% | Buy |
| ROIV | Roivant Sciences | $12.15 | $15.50 | 27.57% | Buy |
| BPMC | Blueprint Medicines | $96.48 | $122.60 | 27.07% | Buy |
| ALNY | Alnylam Pharmaceuticals | $246.58 | $310.60 | 25.96% | Buy |
| KRYS | Krystal Biotech | $169.04 | $210.33 | 24.43% | Buy |
| MDGL | Madrigal Pharmaceuticals | $306.08 | $315.75 | 3.16% | Buy |
| PTCT | PTC Therapeutics | $47.02 | $48.00 | 2.08% | Hold |